Moreover, the potential therapeutic effects of GDF11 on metabolic disorders such as obesity, T2D, glucose and insulin homeostasis dysregulation, and energy imbalance were recently evaluated.21, 27, 33. This evidence concerns the gene GDF11 and obesity due to melanocortin 4 receptor deficiency.